US 11420936
Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases
granted A61PA61P35/00
Quick answer
US patent 11420936 (Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases) held by NIKANG THERAPEUTICS, INC. expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- NIKANG THERAPEUTICS, INC.
- Grant date
- Tue Aug 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P35/00